A further thought and a question.
The next 18 months are likely to be expensive. The Prostact trial is unlikey to be cheap, and it's unclear at the moment how long it will take for Illucix to grow into its share of the higher TAM (or what that share will be). There are also further royalty payments, so I expect expenses to rise with income for 2024. That's not a complaint, if they get therapy to market it will be worth it.
The question- and yes it's a dumb one- presumably they'll be using Illucix to monitor disease progression in the Prostact trials, including the Prostact Select that was recently (partially) reported. So if the therapy's effective presumably there'll be images to back that up eventually?
- Forums
- ASX - By Stock
- CB presenting at Jefferies London this Thursday (3am)
A further thought and a question. The next 18 months are likely...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.44 |
Change
-0.320(1.54%) |
Mkt cap ! $6.840B |
Open | High | Low | Value | Volume |
$20.79 | $21.00 | $20.22 | $19.41M | 945.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $20.42 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.46 | 45 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 20.420 |
1 | 2000 | 20.330 |
1 | 250 | 20.250 |
1 | 495 | 20.230 |
1 | 1000 | 20.200 |
Price($) | Vol. | No. |
---|---|---|
20.630 | 3000 | 1 |
20.750 | 2000 | 1 |
20.970 | 143 | 1 |
20.990 | 1550 | 2 |
21.000 | 9256 | 3 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |